UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children

Condition:   HIV Infection Intervention:   Drug: dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen Sponsors:   PENTA Foundation;   Radboud University Medical Center;   AMS-PHPT Research Collaboration;   Baylor College of Medicine;   University of Zimbabwe Clinical Research Centre (UZCRC);   Clinton Health Access Initiative Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials